PET A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. The usefulness of F-18 FDG PET in infection imaging is based on the fact that granulocytes and macrophages in infectious foci: Have high mitotic rate Have short life span Have high insulin production Have high glucose consumption None 2. A 65-year-old patient is referred for a brain PET/MR study. The referring physician reports placement of a titanium alloy brain clips for an intracranial aneurysm 5 years ago. Which of the following would be the most appropriate action regarding imaging this case? Perform the study regardless the system type or field strength It is contraindicated to perform the exam as titanium alloy is ferromagnetic Perform PET only. Perform the exam using 0.5 Tesla systems or less None 3. All of the following cellular mechanisms are responsible for malignant cells increased F-18 fluorodeoxyglucose accumulation EXCEPT: Low glucose-6-phosphatase. Increased membrane transporters. Increased intracellular hexokinase. Low mitotic rate. None 4. With the administration of oral contrast media for integrated Positron Emission Tomography/Computed Tomography (PET/CT) studies, CT-derived attenuation values are: Not performed Overestimated Underestimated Not applicable None 5. The elevated serum glucose level at the time of fluorodeoxyglucose (FDG) administration may decrease the sensitivity of the FDG-PET study. Althoguh intravenous bolus of insulin may effectively lower the serum glucose level, however induced hyperinsulinemia will: Decrease heart rate. Increase blood pressure. Shunt glucose to skeletal and cardiac muscles. Induce hyperglycemia. None 6. F-18 is a cyclotron-produced radioisotope with a half-life approximately of: 110 min. 11 min. 119 min. 101 min. None 7. High glucose levels may interfere with tumor targeting due to competitive inhibition of FDG uptake by d-glucose. FDG-PET study should not be recommended when the glucose level in the blood exceeds: 175 mg/dl. 200 mg/dl. 120 mg/dl. 155 mg/dl. None 8. The concentration of glucose-6-phosphatase, an enzyme mediating dephosphorylation of FDG-6-phosphate, is low in most tumors EXCEPT: Ductal carcinoma. Hepatocellular carcinoma. Lung adenocarcinoma. Hodgkin lymphoma. None 9. Before FDG administration, the patient relaxes in a waiting room to minimize muscular activity, and in so doing minimizes any physiological uptake of FDG in the muscles. Hyperventilation may cause increased uptake in the: Arm muscles Leg muscles The peritoneum The diaphragm None 10. The time from F-18 fluorodeoxyglucose (FDG) administration to the time of data acquisition has been shown to have a marked effect on FDG uptake. An increased interval between the injection and imaging uptake time will DECREASE radiotracer concentration in: Tumor. Blood pool. Bone marrow. Muscle. None 1 out of 10 Time's upTime is Up! By Nasser AlMutairi|2021-04-07T10:58:49+03:00April 7th, 2021| شارك هذه الصفحة FacebookXLinkedInWhatsAppPinterestEmail About the Author: Nasser AlMutairi Senior Nuclear Medicine Specialist at Hafar Al-Batin Central Hospital, Founder of NuclearMed Website. Leave A Comment Cancel replyComment Δ
Leave A Comment